Question · asked by 1 review

Early ART vs standard or deferred ART (CD4 <= 200 or CD4 <= 250 cells/µl): Death

Population
patients with asymptomatic, HIV‐infected, treatment naive adults
Intervention
Early ART
Comparison
standard or deferred ART (CD4 <= 200 or CD4 <= 250 cells/µl)
Outcome
Death

Early ART probably leads to lower death compared with standard or deferred ART (CD4 <= 200 or CD4 <= 250 cells/µl) (moderate certainty).

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Early ART vs standard or deferred ART (CD4 <= 200 or CD4 <= 250 cells/µl)
Death · patients with asymptomatic, HIV‐infected, treatment naive adults
Early ART probably leads to lower death compared with standard or deferred ART (CD4 <= 200 or CD4 <= 250 cells/µl) (moderate certainty).
Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV‐infected, treatment‐naive adults (2010) · Cochrane Headline outcomes only
RR 0.26 [0.11, 0.62]2 studies · 1065 participantsModerate

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV‐infected, treatment‐naive adults
2010 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.